Envestnet Asset Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$187K Buy
+13,355
New +$187K ﹤0.01% 4250
2023
Q2
Sell
-8,414
Closed -$214K 4091
2023
Q1
$214K Buy
+8,414
New +$214K ﹤0.01% 3626